Press Release | Jul 7, 2026Honigman Advises Lannett Company, Inc. on Its Acquisition by Aurobindo Pharma USA, Inc.

Honigman recently advised Lannett Company, Inc., a leading manufacturer of pharmaceutical products, on its acquisition by Aurobindo Pharma USA, Inc. Following approval from the U.S. Federal Trade Commission on June 18, 2026, the $250 million transaction closed on June 29, 2026.

Founded in 1942, Lannett is a Pennsylvania-based generic pharmaceutical company focused on the development and commercialization of complex, non-opioid controlled substances. Lannett's Indiana manufacturing facility has capacity to produce nearly 4 billion doses annually. The buyer is a subsidiary of Aurobindo Pharma Limited, a multinational pharmaceutical company headquartered in Hyderabad, India operating in over 150 countries.

"Honigman was instrumental in bringing to fruition a company sale that will make Lannett's portfolio of medicines even more affordable and accessible for patients everywhere," said Tim Crew, outgoing CEO of Lannett. "The deal team was pragmatic, creative, and utterly adept at managing the always complex transaction dynamics, which made Honigman a great partner for us."

"This transaction illustrates Honigman's depth and strength in the life sciences sector," said Harold Fox, Ph.D., co-leader of the firm's Life Sciences group and co-chair of Honigman's Intellectual Property Department. "We are pleased to have supported Lannett and other life science clients in closing more than $84 billion in transactions over the last three years."

The Honigman team for Lannett was led by Corporate Department Partners Ryan Opel and Nicholas Pedersen and Associates Mazen Hajali, Moshe Gottesfeld, and Jonathan Winkle, with support from the following Partners and Associates: S. Tony Ling and Alex Burridge (Employee Benefits and Executive Compensation), Jennifer Muse (Labor and Employment), Ilan Napchan (Tax), Clara Seymour and Kylie Densmore-Slinkman (Finance), and Annie Dreisbach (Commercial Transactions). Raymond James & Associates served as exclusive financial advisor to Lannett.